Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD4 | P21917 | 3/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.50 |
| ▸ | CTSB | P07858 | 1/20 | 0.50 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.48 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.46 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9011270 | 0.94 | DRD4 (0.59) | DRD4NPC1RAB9ACAPN1CTSB | |
| SCHEMBL9011249 | 0.89 | DRD4 (0.59) | DRD4NPC1RAB9ACAPN1CTSB | |
| SCHEMBL9010961 | 0.89 | DRD4 (0.60) | DRD4NPC1RAB9ACAPN1CTSB | |
| SCHEMBL27297526 | 0.84 | NPC1 (0.70) | DRD4NPC1RAB9APARP14PARP10 | |
| Trifluoroacetic Acid SCHEMBL4398468 | 0.84 | TPSAB1 (0.63) | — | |
| SCHEMBL7811616 | 0.83 | NPC1 (0.52) | DRD4NPC1RAB9APARP14PARP10 | |
| SCHEMBL9011116 | 0.83 | CCR5 (0.53) | — | |
| SCHEMBL9259543 | 0.83 | DRD4 (0.61) | DRD4NPC1RAB9ACAPN1CTSB | |
| SCHEMBL7811596 | 0.82 | NPC1 (0.51) | DRD4NPC1RAB9APARP14PARP10 | |
| SCHEMBL7817601 | 0.81 | NPC1 (0.54) | DRD4NPC1RAB9APARP14PARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5532371-A | SIDE EFFECT REDUCTION | SS PHARMACEUTICAL CO., LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| US-5411972-A | Arylamide derivatives for treating hyperlipemia | SS PHARMACEUTICAL CO., LTD. (JP) | 1995-05-02 | — | — | US | disclosed |
| EP-0607536-A1 | Arylamide derivatives | SS PHARMACEUTICAL CO., LTD. (JP) | 1994-07-27 | — | — | EP | disclosed |